Human endothelial cells respond t o bacterial endotoxin (lipopolysaccharide ILPSI) with changes that transform the endothelium into a surface with prominent procoagulant properties. Production of tissue factor (TF) in response to LPS is a major alteration that favors coagulation. Biologic activities of LPS have previously been shown t o be enhanced by the presence of hemoglobin. Therefore, the ability of human hemoglobin (Hb) t o modulate TF production by cultured human umbilical vein endothelial cells (HUVEC) was investigated. Cell-free Hb (10 mglmL), either purified native IHbA,) or chemically cross-linked (aaHb), was incubated with LPS (0.1 pg/mL), and the mixtures then were added t o HUVEC in culture. TF activity was quantified with a clotting assay and TF protein was measured with an enzyme-linked immunosorbant assay. Hb preparations greatly enhanced the production of TF activity (11-t o 25-fold greater than TF produced by HUVEC alone) compared with minimal TF activity generated by LPS alone (only twofold greater than HUVEC UMAN ENDOTHELIAL CELLS have a major role in the control of hemostasis. Under normal conditions, the endothelium provides an antithrombotic barrier. Contributing to thromboresistance are the expression of anticoagulant factors such as protein S, thrombomodulin and plasminogen activators,'.' presentation of heparin-like molecules,3 and the inhibition of platelet aggregation by prostacyclin and endothelium-derived relaxing factor? Recently, an inhibitor of the contact activation of coagulation via Hageman factor also has been described.' During gram-negative bacterial sepsis, the presence of bacterial lipopolysaccharide (LPS) results in prominent changes involving the endothelium. Endothelial cells exposed to LPS show overall prothrombotic properties, principally by the synthesis and expression of tissue factor (TF)?' the upregulation of plasminogen activator inhibitor: the down regulation of thrombomodulin, and the inhibition of factor C activation? Leukocyte adhesion is enhanced in the presence of and when human umbili- The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section I734 solely to indicate this fact. This is a US government work. There are no restrictions on its use. 0006-4971/94/8310-0031$0.00/0 2860 alone). The enhancement of LPS-induced TF activity was Hb concentration-dependent over a range of 1 t o 100 mg/mL. Cross-linked aaHb also greatly enhanced the production of TF protein compared with TF protein generated by LPS alone (12-fold greater v3.5-fold greater than HUVEC alone, respectively). The enhancement of LPS-induced TF protein was Hb concentration-dependent over a range of 0.1 t o 2 mg/mL. Enhancement of TF activity by Hb required new protein synthesis. These results show that human Hb can augment the ability of LPS t o induce endothelial cell TF and suggest that hemolysis associated with disseminated intravascular coagulation during sepsis may further stimulate coagulation. In addition, these results suggest a potential mechanism for generalized thrombosis in animals that has been associated with the infusion of cell-free Hb for resuscitation. This is a US government work. There are no restrictions on its use.
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cal vein endothelial cells (HWEC) are incubated with thrombin, a coagulation protease that is commonly generated during endotoxemia, adherence of platelets to HUVEC is increased." These endothelial cell changes in response to LPS and the subsequent prothrombotic activities of the endothelium contribute to the multiple organ failure that is one of the prominent pathologic consequences of gram-negative sepsis.
Cell-free hemoglobin (Hb) can be released from erythrocytes during sepsis as a result of coagulation-mediated intravascular hemolysis or bacterial hemolysin activity.12." Plasma Hb levels were reported to be 1 to 2 mg/mL in patients with intravascular hem~lysis,'~ and plasma Hb levels up to 2 mg/mL have been reported in rabbits with enzymemediated hemolysis'' or endotoxin-mediated intravascular hemolysis.I6 In these studies, released Hb was in excess of the binding capacity of haptoglobin and was detected as free Hb for several hours. Therefore, LPS and considerable concentrations of Hb may coexist in the blood stream during pathologic conditions, and in previous studies in our laboratory, it has been shown that the two molecules form Hb-LPS complexes. '7 In vitro studies and in vivo observations have suggested that significant pathophysiologic consequences result from the biochemical interaction(s) between Hb and LPS. Hb has been shown in vitro to enhance LPSinitiated activation of coagulation'* and to stimulate production of mononuclear cell TF.I9 In vivo, synergism of the toxicities of Hb and LPS (eg, synergistic activation of coagulation"." and complement2' cascades) has been shown, suggesting that enhancement of LPS activity by Hb may contribute to the observed thrombosis, ischemic damage, and multiple organ failure associated with Hb infusion in animals. Therefore, Hb-LPS interactions, resulting from sepsismediated hemolysis, may potentiate the deleterious effects of LPS. In addition, the interaction between Hb and LPS in vivo, with resultant synergism of their pathophysiologic effects, constitutes a major potential limitation in the use of Hb-based oxygen carriers for resuscitation.'' In the present Endotoxin. E coli 026:B6 (W) LPS was purchased from Difco Laboratories.
HUVEC. HUVEC and endothelial cell culture media containing 2% fetal bovine serum, 10 ng/mL epidermal growth factor (EGF) and 1 ng/mL hydrocortisone were purchased from Clonetics (San Diego, CA). HUVEC were plated in 96-well microtiter plates (Nunclon; Applied Scientific, South San Francisco, CA) at a seeding density of 3,500 celldcm2 (5,000 cells/well) and were grown to confluency at 37°C and 5% COz. HUVEC were used at less than 6 passages.
TFprocoagulant assay. TF activity was quantified with a plasma recalcification assay. Confluent HUVEC monolayers in 96-well plates were incubated for 4 hours at 37°C with 10 pL E coli LPS alone, HbA, or aaHb alone, or Hb-LPS mixtures in 90 pL medial well. Standard incubations were conducted using 10 mg/mL Hb.
Experiments were performed with 6 to 8 replicate wells. Wells were then washed with media (X3) and the HUVEC were freeze-thawed twice and sonicated in 50 pL phosphate-buffered saline for 2 minutes at room temperature. To each well then was added 50 pL normal human citrated plasma and 50 pL calcium (25 mmoVL), and after 8 minutes, turbidity was measured at 340 nm in a 37°C temperaturecontrolled plate reader (Kinetic-QLC; Whittaker Bioprcducts Inc, Walkersville, MD). TF activity was calculated from the turbidity generated in plasma (the mean from 6 to 8 replicate welts) by a standard curve established with dilutions of rabbit brain thromboplastin (Baxter Corporation, Miami, FL). The turbidity generated at 8 minutes by 1: 100 diluted thromboplastin was defined as 1 TF arbitrary unit.
TF protein assay. Confluent HUVEC monolayers in 96-well plates were incubated for 4 hours at 37°C with 10 pL E coli LPS alone, HbA, or aaHb alone, or Hb-LPS mixtures in 90 pL media/ well. Standard incubations were conducted using 2 mg/mL Hb. Experiments were performed with 6 to 8 replicate wells. Wells were then washed with media (X3), and the HUVEC were freeze-thawed twice and sonicated in 50 pL phosphate buffered saline; 10 pL Triton X-IO0 was added (final concentration, l%), and incubations were continued overnight at 4°C. The solutions were then removed from the plates and centrifuged for 15 minutes (Microfuge B; Beckman Instruments, Inc, Palo Alto, CA). TF was quantified by enzymelinked immunosorbant assay (ELISA) using a murine antihuman TF monoclonal antibody (Imubind; generously provided by American Diagnostica, Inc, Greenwich, CT) according to the manufacturer's directions. 
RESULTS
HUVEC contained undetectable or very low TF activity (<O. 1 TF unit), as determined by the plasma recalcification assay. After incubation with E coli LPS, a concentrationdependent and time-dependent stimulation of HUVEC TF production was observed. In a representative experiment, stimulation of TF activity ranged from 1.4-fold over baseline, after 4-hour incubation with 0.01 pg/mL LPS, to 17.5-fold over baseline, after incubation with 10 pg/mL LPS ( Fig  1A) . At 100 p g / d or 1 m g / d LPS, TF production in some experiments was less than the TF produced by 10 p g / d LPS and, in other experiments, was equivalent. The increase in TF was detectable after 2 hours of incubation with LPS and became maximal between 4 and 6 hours (data not Various types of purified LPS were incubated with HUVEC for 4 hours, and TF activities were determined. The LPS that elicited the least TF response by the HUVEC (S minnesota lipid A) was assigned a relative procoagulant activity of 1, and the biologic activities of the other LPSs are presented in comparison to lipid A.
* S minnesota lipid A. t S minnesota 595.
* Protens rnirabilis R110. shown). Similar LPS concentration-dependent TF responses were detected in 8 independent experiments; the maximal TF activities from LPS-treated HUVEC (achieved with 10 pg/mL LPS) were from 7 to 28 times greater (mean, 16 times greater) than the TF activity of untreated HUVEC. TF responses varied considerably when different glycolipids were examined ( Table 1) . A low TF response was observed with S minnesota lipid A (which consists of a diglucosamine backbone and seven fatty acyl chains) compared with other LPSs which contained additional saccharide moieties, suggesting that 0-chain and core carbohydrates are important for the HUVEC response. We also quantified HUVEC TF protein by a sensitive ELISA assay. In an experiment representative of 6 independent studies, TF protein increased in an LPS concentration-dependent manner from 17 pg/well in untreated HUVEC to 116 pg/well in HUVEC after 4 hr incubation with 10 pg/ml LPS (Fig 1B) . Total protein per well was unchanged at 41 t 4 pg/well. In each of the 6 studies, LPS-treated HUVEC showed both increased TF functional activity and increased antigenic concentrations of TF protein.
To further demonstrate that the TF activity induced by LPS resulted from newly formed protein rather than by a process of enhanced catalytic activity by preexisting TF protein, we examined the effect of protein synthesis inhibitors. LPS-stimulated TF production was completely inhibited by actinomycin D or cycloheximide (Fig 2) , providing additional evidence that the cellular procoagulant response to LPS required new protein synthesis.
To test the effect of Hb on the production of HUVEC TF in response to LPS, two Hb preparations were investigated. HbA, was used because this preparation was native Hb and would be potentially available to interact with the endothelium during in vivo hemolysis of erythrocytes. aaHb was used because this chemically stabilized preparation is not susceptible to dissociation of the a-chains of the Hb tetrame?' and is a form of Hb that is presently being developed as a cell-free blood substitute. Hb (10 mg/mL) was first incubated with LPS for 30 minutes at 37°C and the mixtures then were added to HUVEC. A low concentration of LPS was used (0.1 pg/mL) so that only modest TF production by HUVEC was generated in response to LPS alone. At this concentration, HUVEC incubated with LPS generated only 2.5-fold greater TF activity than unstimulated HUVEC (Fig  3) . HbA, or a a H b alone (10 mg/rnL each) did not demonstrably increase the very low levels of TF activity produced by HUVEC in the absence of LPS. In contrast, stimulation of TF production from HUVEC was 1 l-fold increased in the presence of the LPS-HbA, mixture and was 25-fold increased in the presence of the LPS-aaHb mixture. Preincubation of Hb and LPS longer than 30 minutes before their addition to HUVEC did not alter this response.
The enhanced TF production in the presence of various concentrations of Hb was concentration-dependent, as is shown for HbA, (Fig 4A) . A similar response to increasing concentrations of HbA, was observed when experiments were performed with aaHb (data not shown). Supernatants of the HUVEC cultures did not contain detectable TF activity, even after incubation with LPS or LPS-Hb mixtures (data not shown). ELISAs showed Hb concentration-dependent synthesis of new TF protein in response to LPS-Hb mixtures (Fig 4B) . In this representative experiment, TF protein production was stimulated 3.9-fold over baseline by 1 pg/mL LPS (in the absence of Hb) and 11.8-fold over baseline in the presence of LPS and 2 mg/mL aaHb. This represents a threefold enhancement in TF protein production because of aaHb. In 4 independent experiments, maximum TF concentrations (pg/well) produced in response to Hb-LPS mixtures were 2.1-to 6.5-fold greater (mean, 3.7-fold) than the concentrations of "F protein produced in response to LPS alone.
To determine whether the enhancement of LPS-elicited TF production in the presence of Hb was the result of new TF protein production, HUVEC were incubated with LPS and Hb in the presence of actinomycin D or cycloheximide. Each of the protein synthesis inhibitors totally prevented the generation of TF activity, indicating that the mechanism for the Hb enhancement process involved new protein synthesis (Fig 5) .
DISCUSSION
Despite the extensive existing knowledge of the structure of human Hb and its function within the erythrocyte, relatively little is known about pathophysiologic interactions involving extraerythrocytic Hb and other blood elements and host tissues. Clinical evidence of renal, vascular, and reticuloendothelial system damage during hemolytic episodes has suggested that extraerythrocytic Hb (and, in particular, Hb breakdown products such as hematin) can be However, the direct effects of Hb have been difficult to determine because the contribution to the observed toxicities from erythrocyte membrane components is also felt to be of major importance?1.28 Similarly, in determining the mechanism of organ toxicity associated with LPS-mediated intravascular coagulation with resultant hemolysis, it is difficult to distinguish the contribution of Hb to the observed deleterious effects from the contribution by LPS.20.21. 28 The elucidation of LPS-mediated toxicity itself is difficult because of the high potency and the protean biologic activities of LPS. The potential for LPS and cell-free Hb to interact in the blood stream adds additional complexity to an understanding of the consequences of extraerythrocytic Hb.
The current efforts to develop cell-free Hb as a transfusion product have allowed detailed investigation of the interactions between Hb and LPS. Previously, we had shown that there is a biologically significant interaction between Hb and Because of the prothrombotic actions of LPS on the vascular endothelium, it was important to investigate the potential ability of Hb to modify this critical interaction during endotoxemia. The present studies showed that HbA, significantly increased TF activity in HUVEC in response to LPS. This effect was observed at concentrations of Hb (1 to 2 mg/ mL) that can be encountered in plasma during clinical and experimental end~toxemia.'~"~ This Hb preparation did not contain detectable erythrocyte stroma that could potentially elicit a HUVEC response. The enhanced TF activity resulted from new TF protein synthesis. The mechanism of this effect is uncertain because the mechanism of LPS signal transduction in HUVEC is not known. However, the demonstration in our laboratory that Hb binds LPS and causes LPS dissociation" suggests that disaggregated and/or protein-bound LPS has an increased ability to interact with HUVEC LPS receptors and trigger the procoagulant response. Thus, the Hb enhancement effect may represent the result of presentation to the endothelial cell of a "modified" (eg, disaggregated) LPS. Additionally, a number of other potential mechanisms may be involved. Preliminary studies in our laboratory have shown that LPS induces the denaturation of Hb to methemoglobin and hemichrome, species of Hb that may show altered biologic activity and produce oxygen-free radicals during their formation.
Based on these results using HbA.,, it is reasonable to propose that hemolysis caused by LPS-mediated disseminated intravascular coagulation may constitute a positive feedback loop to amplify coagulation. Additionally, enhancement of other LPS biologic activities by HbA,, such as mononuclear cell cytokine production, may contribute to the often fatal consequences of low level endotoxemia (during which LPS concentrations are frequently measured in the 10 to 100 pg/mL range29.30). The present study also showed enhancement of the TF response to LPS by aaHb, a crosslinked preparation of human Hb that is a leading candidate for use as a blood substitute. These findings raise two concerns for the human use of cell-free Hb. Firstly, contamination of Hb preparations by environmental LPS is difficult to avoid." Because large volumes of Hb would be required for resuscitation, the procoagulant consequences of LPS contamination in the Hb preparations could limit the use of aaHb. In patients receiving Moth blood volume of aaHb for resuscitation, blood Hb levels 210 m g h L would be achieved. At these concentrations of Hb, substantial enhancement by Hb of the procoagulant activity of any LPS in the circulation would be expected based on our results. Secondly, aaHb would likely be infused into some patients with coexisting endotoxemia. Endotoxemia could arise from gram-negative bacteremia, from reticuloendothelial system dysfunction, and/or from increased gastrointestinal tract translocation of LPS into the circulation secondary to hypotension or trauma. Consequently, aaHb infusion could potentially enhance the systemic pathologic effects of underlying endotoxemia. Because of the demonstration of the in vitro consequences of the interaction between LPS and Hb, which provide a basis for potential thrombotic effects, it is important that future studies investigate the ability of Hb to enhance LPS-induced coagulation in vivo.
